Treatment of Urate Nephropathy in Patients with Acute Polyarticular Gout Attack
Management of Acute Polyarticular Gout Attack
- For patients with urate nephropathy and acute polyarticular gout, treatment should include aggressive management of the acute attack with anti-inflammatory agents while simultaneously addressing the underlying hyperuricemia, with appropriate dose adjustments for renal function, as recommended by the American College of Rheumatology 1, 2
- For severe polyarticular attacks, initial combination therapy is appropriate, particularly with involvement of multiple large joints, according to the American College of Rheumatology 1, 3
- Recommended combination approaches include colchicine plus NSAIDs, as suggested by the American College of Rheumatology 4
- Oral corticosteroids plus colchicine is another recommended combination approach, as per the American College of Rheumatology 3
- Intra-articular steroids with any other modality can be used, as recommended by the American College of Rheumatology 1
Specific Medication Recommendations
- Oral prednisone 0.5 mg/kg per day for 5-10 days at full dose then stop, or 2-5 days at full dose followed by 7-10 day taper, is recommended by the American College of Rheumatology 3, 2
- Intra-articular steroids can be used for 1-2 affected joints, as suggested by the American College of Rheumatology 2
- For severe cases, IV methylprednisolone at 0.5-2.0 mg/kg may be appropriate, according to the American College of Rheumatology 5
- If not already on prophylactic colchicine, 1.2 mg followed by 0.6 mg one hour later, then continue with prophylactic dosing 12 hours later, is recommended by the American College of Rheumatology 3
Management of Urate Nephropathy
- Continue ongoing urate-lowering therapy (ULT) without interruption during the acute attack, as recommended by the American College of Rheumatology 2
Prophylaxis During Urate-Lowering Therapy
- Anti-inflammatory prophylaxis should be initiated with or just prior to ULT, according to the American College of Rheumatology 4
- Low-dose colchicine (0.6 mg once or twice daily, adjusted for renal function) is first-line, as recommended by the American College of Rheumatology 4
- Low-dose prednisone (<10 mg/day) is an option if colchicine and NSAIDs are contraindicated, as suggested by the American College of Rheumatology 4
- Continue prophylaxis for at least 6 months, or 3-6 months after achieving target serum urate levels, as recommended by the American College of Rheumatology 4
Monitoring
- Assess for resolution of acute gout symptoms and adjust therapy accordingly, as recommended by the American College of Rheumatology 2